Regeneron Pharmaceuticals (REGN) has secured a landmark FDA approval for its monoclonal antibody garetosmab, now commercially known as Pasatru, after more than ten years in development. The drug becomes the second FDA-cleared
More
President Donald Trump is expected to nominate Heidi Overton, a physician and White House domestic policy aide, to lead the Food and Drug Administration. The move, reported by a source familiar with
More
The U.S. Citizenship and Immigration Services has issued an interim final rule establishing a framework for requiring certain immigration benefit requests to be filed electronically. The rule, published on August 11, 2026,
More
California agriculture employers are facing increasing scrutiny from Cal/OSHA, with regulators actively targeting farms and agricultural businesses across the state. Legal experts Kevin Bland and Karen Tynan have outlined the most common
More
The Justice Department has filed its opposition to James Comey’s motions to dismiss the so-called seashell case, submitting its most detailed defense of the indictment yet. The federal government is prosecuting the
More
Pennsylvania’s Attorney General’s office has charged fourteen people in connection with a drug operation it branded “Operation Drugs Unlimited,” targeting cocaine distribution at Penn State. Thirteen of the fourteen individuals charged were
More
Ithaca Energy (LSE: ITH) is drawing serious attention from income investors thanks to a dividend forecast that comfortably outpaces the wider FTSE 100 average yield of 3.03%. The company is one of
More
The S&P 500 has continued to attract bullish sentiment from Wall Street analysts even as rising oil prices introduce fresh uncertainty into financial markets. Higher energy costs have historically weighed on corporate
More
Harbour Energy (HBR) is targeting a shareholder return of 15% in 2026, driven by what the company describes as bumper cash flows from its operations. The North Sea-focused oil and gas producer
More
Aurobindo Pharma’s sterile injectables and oncology division Eugia has received a fresh FDA Warning Letter following an inspection of its Pharma Specialties facilities in Hyderabad in February. The warning letter comes after
More